These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 16545870)

  • 21. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble HLA revisited.
    Tabayoyong WB; Zavazava N
    Leuk Res; 2007 Feb; 31(2):121-5. PubMed ID: 16860865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
    Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
    Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
    Li D; Li G; Wang B
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
    Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
    Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma.
    Pedersen LM; Klausen TW; Davidsen UH; Johnsen HE
    Ann Hematol; 2005 Aug; 84(8):510-6. PubMed ID: 15834569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
    J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
    Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
    Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.
    Bono P; Teerenhovi L; Joensuu H
    Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma.
    Lee HL; Eom HS; Yun T; Kim HJ; Park WS; Nam BH; Moon-Woo S; Lee DH; Kong SY
    Cytokine; 2008 Jul; 43(1):71-5. PubMed ID: 18502145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.